A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.

@article{Prager2002ARD,
  title={A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.},
  author={N. Prager and K. Bickett and N. French and Geno Marcovici},
  journal={Journal of alternative and complementary medicine},
  year={2002},
  volume={8 2},
  pages={
          143-52
        }
}
BACKGROUND Androgenetic alopecia (AGA) is characterized by the structural miniaturization of androgen-sensitive hair follicles in susceptible individuals and is anatomically defined within a given pattern of the scalp. [...] Key MethodSUBJECTS Included in this study were males between the ages of 23 and 64 years of age, in good health, with mild to moderate AGA. RESULTS The results of this pilot study showed a highly positive response to treatment.Expand
A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia
Multi‐therapies in androgenetic alopecia: review and clinical experiences
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia.
Preventing diseases of the prostate in the elderly using hormones and nutriceuticals
  • F. Comhaire, A. Mahmoud
  • Medicine
  • The aging male : the official journal of the International Society for the Study of the Aging Male
  • 2004
Herbs for Benign Prostatic Hyperplasia
Mechanism of action of androgen in hair follicles.
Phytotherapy for benign prostatic hyperplasia
...
1
2
3
4
5
...